Jubilant Pharmova announced on Saturday (September 20) that it has cleared a USFDA inspection at its US subsidiary with zero observations, reaffirming its strong compliance…

General Atlantic has pared its stake in Rubicon Research ahead of the pharma company’s ₹1,085 crore IPO, raising ₹140 crore through a share sale. The…

Zydus Lifesciences has received a positive compliance update from the USFDA for its Ahmedabad-based oncology injectable facility, which has now been classified as Voluntary Action…

This week, markets will first react to the US imposing an annual fee of $100,000 on H-1B visas, announced late Friday. On the domestic front,…

Monday’s moves will all depend on how India’s IT stocks react to the Trump administration’s H-1B visa announcements. The US-listed shares of Infosys and Wipro…

India and China are cautiously recalibrating their economic ties in 2025, with bilateral trade reaching $127.7 billion in FY25, marking a fourfold increase over the…

Key stocks to watch: PNC Infratech, Hariom Pipe Industries, Oil India, HUDCO, Netweb Technologies, and Brigade Enterprises have all secured major orders, projects, or investments,…

The company said it will address the observations and respond to the FDA within the stipulated timeframe, reaffirming its commitment to current Good Manufacturing Practices…

The agreement involves the assignment of a Device Distribution and Supply Agreement with Vodafone Dağıtım, Servis ve İçerik Hizmetleri AS, and will be effective from…

The Trump Administration has announced a historic shakeup to the H-1B visa programme, raising the fee to $100,000 as well as the prevailing wage requirements.…